Adaptive Resistance to Immunotherapy Directed Against p53 Can be Overcome by Global Expression of Tumor-Antigens in Dendritic Cells.
Saved in:
| Title: | Adaptive Resistance to Immunotherapy Directed Against p53 Can be Overcome by Global Expression of Tumor-Antigens in Dendritic Cells. |
|---|---|
| Authors: | Humar M; Pharmaceutical Biology and Biotechnology, Albert-Ludwigs-University of Freiburg , Freiburg , Germany., Azemar M; Internistische Onkologie, Tumor Biology Center , Freiburg , Germany., Maurer M; Basilea Pharmaceutica International Ltd. , Basel , Switzerland., Groner B; Institute for Biomedical Research, Georg Speyer Haus , Frankfurt am Main , Germany. |
| Source: | Frontiers in oncology [Front Oncol] 2014 Oct 06; Vol. 4, pp. 270. Date of Electronic Publication: 2014 Oct 06 (Print Publication: 2014). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 25340039 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Adaptive Resistance to Immunotherapy Directed Against p53 Can be Overcome by Global Expression of Tumor-Antigens in Dendritic Cells. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Humar+M%22">Humar M</searchLink>; Pharmaceutical Biology and Biotechnology, Albert-Ludwigs-University of Freiburg , Freiburg , Germany.<br /><searchLink fieldCode="AU" term="%22Azemar+M%22">Azemar M</searchLink>; Internistische Onkologie, Tumor Biology Center , Freiburg , Germany.<br /><searchLink fieldCode="AU" term="%22Maurer+M%22">Maurer M</searchLink>; Basilea Pharmaceutica International Ltd. , Basel , Switzerland.<br /><searchLink fieldCode="AU" term="%22Groner+B%22">Groner B</searchLink>; Institute for Biomedical Research, Georg Speyer Haus , Frankfurt am Main , Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2014 Oct 06; Vol. 4, pp. 270. <i>Date of Electronic Publication: </i>2014 Oct 06 (<i>Print Publication: </i>2014). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=25340039 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fonc.2014.00270 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 270 Titles: – TitleFull: Adaptive Resistance to Immunotherapy Directed Against p53 Can be Overcome by Global Expression of Tumor-Antigens in Dendritic Cells. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Humar M – PersonEntity: Name: NameFull: Azemar M – PersonEntity: Name: NameFull: Maurer M – PersonEntity: Name: NameFull: Groner B IsPartOfRelationships: – BibEntity: Dates: – D: 06 M: 10 Text: 2014 Oct 06 Type: published Y: 2014 Identifiers: – Type: issn-print Value: 2234-943X Numbering: – Type: volume Value: 4 Titles: – TitleFull: Frontiers in oncology Type: main |
| ResultId | 1 |
